Download presentation
Presentation is loading. Please wait.
Published byEleanor Marsh Modified over 6 years ago
1
Primary treatment and prognostic factors of small cell neuroendocrine carcinoma of the uterine cervix: A Taiwanese Gynecologic Oncology Group study Kung-Liahng Wang, Ting-Chang Chang, Shih-Ming Jung, Chi-Hau Chen, Ya-Min Cheng, Hua-Hsi Wu, Wen-Shiung Liou, Shih-Tien Hsu, Yu-Che Ou, Lian-Shung Yeh, Hung-Cheng Lai, Chia-Yen Huang, Tze-Chien Chen, Chee-Jen Chang, Chyong-Huey Lai European Journal of Cancer Volume 48, Issue 10, Pages (July 2012) DOI: /j.ejca Copyright © 2011 Elsevier Ltd Terms and Conditions
2
Fig. 1 (A) Cancer-specific survival according to the primary treatment in the International Federation of Gynaecology and Obstetrics (FIGO) stages IIB–IV: concurrent chemoradiation with etoposide and platinum of ⩾5 courses (CCRT-EP5+, n=8) versus other treatments (n=48); (B) Failure-free survival according to primary treatment in FIGO stages IIB–IV: CCRT-EP5+ versus other treatments. European Journal of Cancer , DOI: ( /j.ejca ) Copyright © 2011 Elsevier Ltd Terms and Conditions
3
Fig. 2 (A) Cancer-specific survival according to the primary treatment in the International Federation of Gynaecology and Obstetrics (FIGO) stages IA–IIB: primary treatment containing surgery (OP+, n=116) versus other treatments (n=30); (B) Failure-free survival according to primary treatment in FIGO stages IA–IIB: OP+ versus other treatments. European Journal of Cancer , DOI: ( /j.ejca ) Copyright © 2011 Elsevier Ltd Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.